Pipeline

Mode of action Product Candidate / PROGRAM Drug substance Indication Discovery Pre-clinical Phase 1 Phase 2 Phase 3/ Pivotal EMA/FDA review Commercial Rights
Cancer Metabolism Tumor Starvation eryaspase (GRASPA® (1)) Asparaginase Pancreatic Cancer
ALL

Europe

Israel

US and RoW

AML
Solid tumors
erymethionase Methionine-γ-lyase Solid tumors  
eryminase Arginine deiminase Solid tumors  
Enzyme therapies ERYZYME Therapeutic enzymes Metabolic diseases  
Immunotherapy ERYMMUNE Tumor antigens TBD  

Arrow indicates most advanced study within an indication or program; more detail is provided in subsequent slides
(1) Brand name for eryaspase in Europe and Israel

Top